{
  "authorized_claims": [
    {
      "market": "EFSA",
      "framework_reference": "Reg 432/2012",
      "claim_verbatim": "Protein contributes to a growth in muscle mass.",
      "authorization_date": "2012",
      "conditions": "Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a \"source of protein\" — ≥ 12% of energy value provided by protein"
    },
    {
      "market": "EFSA",
      "framework_reference": "Reg 432/2012",
      "claim_verbatim": "Protein contributes to the maintenance of muscle mass.",
      "authorization_date": "2012",
      "conditions": "Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a \"source of protein\" — ≥ 12% of energy value provided by protein"
    },
    {
      "market": "EFSA",
      "framework_reference": "Reg 432/2012",
      "claim_verbatim": "Protein contributes to the maintenance of normal bones.",
      "authorization_date": "2012",
      "conditions": "Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a \"source of protein\" — ≥ 12% of energy value provided by protein"
    },
    {
      "market": "ANVISA",
      "framework_reference": "IN 28/2018 Anexo V alegação funcional",
      "claim_verbatim": "As proteínas auxiliam na formação dos músculos e ossos.",
      "authorization_date": "2018",
      "conditions": "IN 28/2018 Anexo V: alegação restrita aos suplementos cuja quantidade de proteína e perfil de aminoácidos essenciais atendam os Anexos III + VII"
    }
  ],
  "slug": "pea-protein",
  "name": "Pea Protein (Yellow Split Pea Isolate · Concentrate)",
  "alternate_names": [
    "Pea protein isolate",
    "Yellow pea protein",
    "Pisum sativum protein"
  ],
  "mechanism": [
    "Plant-source protein with relatively high leucine content among legumes (~8% of total AA)",
    "mTORC1 / muscle protein synthesis activation when dose-matched to whey",
    "Lower methionine and cysteine content vs animal sources (limiting amino acids)"
  ],
  "target": [
    "Skeletal muscle protein synthesis (Babault 2015 muscle thickness gains)",
    "Plant-based dietary protein adequacy"
  ],
  "use_case": [
    "plant-based diet protein adequacy",
    "muscle thickness gains during resistance training",
    "dairy-free / soy-free alternative",
    "sarcopenia prevention"
  ],
  "body_system": [
    "MUSCULO",
    "METABOLISM"
  ],
  "evidence_tier": "B",
  "evidence_anchor_pmid_count": 2,
  "dosage_range": "25 g twice daily during resistance training for muscle thickness gains (Babault 2015 PMID 25628520 JISSN RCT n=161 males 18-35 · 12 weeks · double-blind placebo-controlled · pea > placebo significant on muscle thickness · pea ≈ whey without a significant inter-group difference)",
  "safety_notes": "Pea allergy is possible but uncommon; generally well-tolerated; lower digestibility-corrected amino acid score (PDCAAS ~0.7) vs whey (1.0), so consider blending with rice protein for a complete amino acid profile",
  "regulatory": {
    "fda": "GRAS · DSHEA dietary supplement · no specific health claim · qualifies for 21 CFR 101.79 \"good source of protein\" (≥ 10% DV) when serving size meets the threshold",
    "efsa": "Authorized protein claims (Reg 432/2012) for muscle mass + bone maintenance available when food source provides ≥ 12% energy from protein",
    "anvisa": "RDC 243/2018 dietary supplement · IN 28/2018 Anexo V alegação funcional verbatim: \"As proteínas auxiliam na formação dos músculos e ossos.\" (Anexo III ≥ 8,4 g/dia adultos ≥ 19 anos · Anexo VII proteína de referência AAE/g)"
  },
  "ingredient_hub_url": "https://asxan.ai/ingredients/pea-protein/",
  "related_goal_slugs": [
    "athletic-performance",
    "weight-management",
    "longevity-stack"
  ],
  "related_lifestyle_slugs": [
    "plant-based",
    "athletic-performance",
    "senior-60-plus"
  ],
  "last_evidence_review": "2026-06-04",
  "schema_version": "nc-public-v0.2",
  "api_version": "nc-public-v0.3",
  "_meta": {
    "last_evidence_review": "2026-06-04",
    "ip_axes_disclosed": {
      "public_axes": [
        "mechanism",
        "target",
        "use_case",
        "body_system",
        "evidence_tier",
        "dosage_range",
        "safety_notes",
        "regulatory",
        "authorized_claims"
      ],
      "ip_axes_not_exposed": [
        "proprietary_formula_ratios",
        "clinical_protocol_internals",
        "rnd_pipeline_compounds",
        "supplier_specific_grade_specifications",
        "unpublished_endpoint_data"
      ],
      "rationale": "asxan.ai surfaces the educational, evidence-tier-disclosed slice. Formula composition, clinical-protocol internals, and RnD pipeline data are intentionally outside this public surface."
    }
  }
}